The process for the detection of monoclonal gammopathies (MGs) is highly complex. To obtain an accurate diagnosis, diagnostic data must be compiled from several areas of the laboratory (eg, total protein, immunoglobulin levels, gel or capillary electrophoreses patterns).
“Laboratory Detection and Initial Diagnosis of Monoclonal Gammopathies,” establishes recommendations that pathologists and clinicians can implement to better manage testing and improve the accurate diagnoses of patients with monoclonal gammopathies (MGs).
- Guideline Status: Active
- Published online ahead of print: August 4, 2021
- Originally published: May 2022
Guideline Tools & Resources
The following tools and resources are available to help implement the guideline:
American Association for Clinical Chemistry
American Society for Clinical Pathology
American Society of Hematology
International Myeloma Working Group
Review more upcoming CAP evidence-based guidelines by the Center.